The HALO chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the HALO chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The HALO stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View HALO Detailed Price Forecast - CNN Money||View HALO Detailed Summary - Google Finance|
|View HALO Detailed Summary - Yahoo! Finance||View HALO Stock Research & Analysis - Zacks.com|
|View HALO Trends & Analysis - Trade-Ideas||View HALO Major Holders - Barrons|
|View HALO Call Transcripts - NASDAQ||View HALO Breaking News & Analysis - Seeking Alpha|
|View HALO Annual Report - CompanySpotlight.com||View HALO OTC Short Report - OTCShortReport.com|
|View HALO Fundamentals - TradeKing||View HALO SEC Filings - Bar Chart|
|View Historical Prices for HALO - The WSJ||View Performance/Total Return for HALO - Morningstar|
|View the Analyst Estimates for HALO - MarketWatch||View the Earnings History for HALO - CNBC|
|View the HALO Earnings - StockMarketWatch||View HALO Buy or Sell Recommendations - MacroAxis|
|View the HALO Bullish Patterns - American Bulls||View HALO Short Pain Metrics - ShortPainBot.com|
|View HALO Stock Mentions - StockTwits||View HALO Stock Mentions - PennyStockTweets|
|View HALO Stock Mentions - Twitter||View HALO Investment Forum News - Investor Hub|
|View HALO Stock Mentions - Yahoo! Message Board||View HALO Stock Mentions - Seeking Alpha|
|View Insider Transactions for HALO - SECform4.com||View Insider Transactions for HALO - Insider Cow|
|View HALO Major Holdings Summary - CNBC||View Insider Disclosure for HALO - OTC Markets|
|View Insider Transactions for HALO - Yahoo! Finance||View Institutional Holdings for HALO - NASDAQ|
|View HALO Stock Insight & Charts - FinViz.com||View HALO Investment Charts - StockCharts.com|
|View HALO Stock Overview & Charts - BarChart||View HALO User Generated Charts - Trading View|
Free Technical Research on ImmunoGen and Three More Biotech Equities
Posted on Friday June 22, 2018
On Thursday, June 21, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged lower at the closing bell. Eight out of nine sectors ended Thursday's trading session in bearish territories. Taking into consideration yesterday's market sentiment, WallStEquities.com assessed the following Biotechnology equities this morning: Grifols S.A. (NASDAQ: GRFS), Halozyme Therapeutics Inc. (NASDAQ: HALO), ImmunoCellular Therapeutics Ltd (NYSE AMER: IMUC), and ImmunoGen Inc. (NASDAQ: IMGN).
Report: Exploring Fundamental Drivers Behind Virtu Financial, Littelfuse, Gogo, Brookfield Asset Management, Protalix BioTherapeutics, and Halozyme Therapeutics — New Horizons, Emerging Trends, and Upcoming Developments
Posted on Wednesday June 13, 2018
NEW YORK, June 13, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Virtu ...
Halozyme President And Chief Executive Officer, Dr. Helen Torley Named EY Entrepreneur Of The Year 2018 San Diego
Posted on Monday June 11, 2018
SAN DIEGO, June 11, 2018 /PRNewswire/ -- Halozyme Therapeutics, Inc. (HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today announced Dr. Helen Torley, president and chief executive officer, was awarded the honor of Entrepreneur Of The Year® 2018 San Diego in the category of Operational Excellence by a panel of independent judges. The EY Entrepreneur Of The Year program recognizes the endeavors of exceptional entrepreneurs who are excelling in areas such as innovation, financial performance and personal commitment to their businesses and communities. "Under Helen's leadership, Halozyme has not only made significant progress growing the ENHANZE technology franchise and studying the potential for our investigational oncology drug, but also in strengthening our culture and commitment to excellence.
See what the IHS Markit Score report has to say about Halozyme Therapeutics Inc.
Posted on Friday June 08, 2018
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.